BioCatalyst

CC-92480, Bortezomib, Dexamethasone, Daratumumab — catalyst calendar

1 verified catalyst event(s) referencing CC-92480, Bortezomib, Dexamethasone, Daratumumab, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-30
in 4mo
ESTIMATED
 READOUT
A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety
Phase 1/2 · Multiple Myeloma
 Celgene CC-92480, Bortezomib, Dexamethasone, Dar ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.